ActualEyes Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ActualEyes Inc. - overview
Established
2018
Location
Kyotanabe-shi, Kyoto, Japan
Primary Industry
Healthcare Specialists
About
Based in Kyoto, Japan, and founded in 2018, ActualEyes Inc. operates as a biotechnology company developer of medical technology specializing in research and developing novel pharmaceutical and cell therapies based upon seed research. In August 2019, ActualEyes Inc. raised venture funding from a Japan Science and Technology Agency.
As of 2023, Iku Sugioka is operating as chief Executive Officer of ActualEyes Inc. ActualEyes Inc. provides regenerative medicine and eye drops intended to treat Fuchs corneal endothelial dystrophy. The company offers research and development of therapeutic agents and products such as regenerative medicine to meet the unmet medical needs for corneal endothelium disorders, enabling healthcare providers to treat patients suffering from corneal endothelial dystrophy effectively.
Current Investors
Japan Science and Technology Agency
Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services, Pharmaceuticals, Pharmaceutical Research & Development
Website
www.actualeyes.co.jp
Company Stage
Series C
Total Amount Raised
Subscriber access only
ActualEyes Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | - | - | - | - | - |
| Operating Margin | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (8,275,000) | (79,716,104) | - | - | - |
| % Net Margin | - | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.